Michael R. Minogue - Nov 3, 2021 Form 4 Insider Report for ABIOMED INC (ABMD)

Signature
/s/ Marc A Began (by power of attorney)
Stock symbol
ABMD
Transactions as of
Nov 3, 2021
Transactions value $
-$1,804,062
Form type
4
Date filed
11/5/2021, 04:30 PM
Previous filing
Oct 4, 2021
Next filing
May 26, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ABMD Common Stock $.01 par value Award $0 +23.3K +10.98% $0.00 235K Nov 3, 2021 Direct F4
transaction ABMD Common Stock $.01 par value Tax liability -$1.8M -5.16K -2.2% $349.76 230K Nov 3, 2021 Direct F5
holding ABMD Common Stock $.01 par value 52.6K Nov 3, 2021 By Trust - A
holding ABMD Common Stock $.01 par value 73.7K Nov 3, 2021 By Trust - B
holding ABMD Common Stock $.01 par value 32.8K Nov 3, 2021 By Trust - C
holding ABMD Common Stock $.01 par value 655 Nov 3, 2021 By Trust - D
holding ABMD Common Stock $.01 par value 38.6K Nov 3, 2021 By Trust - E
holding ABMD Common Stock $.01 par value 85K Nov 3, 2021 By Trust - F

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ABMD Stock Option (right to buy) 85K Nov 3, 2021 Common Stock 0 $21.55 Direct F1, F2
holding ABMD Stock Option (right to buy) 35K Nov 3, 2021 Common Stock 0 $66.25 Direct F1, F2
holding ABMD Stock Option (right to buy) 30.5K Nov 3, 2021 Common Stock 0 $99.62 Direct F2, F3
holding ABMD Stock Option (right to buy) 33K Nov 3, 2021 Common Stock 0 $134.51 Direct F2, F3
holding ABMD Stock Option (right to buy) 30K Nov 3, 2021 Common Stock 0 $381.97 Direct F2, F3
holding ABMD Stock Option (right to buy) 50K Nov 3, 2021 Common Stock 0 $266.39 Direct F2, F3
holding ABMD Stock Option (Right to Buy) 20.9K Nov 3, 2021 Common Stock 0 $223.90 Direct F2, F3
holding ABMD Stock Option (Right to Buy) 30K Nov 3, 2021 Common Stock 0 $283.88 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2008 Stock Incentive Plan.
F2 These options become exercisable in annual 33-1/3% increments, commencing on the date shown in Table II, Column 6.
F3 Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2015 Omnibus Incentive Plan.
F4 Represents shares of common stock underlying performance-based awards of restricted stock units granted to this reporting person on November 5, 2020. One half of these restricted stock units vested on November 3, 2021 (into an equal number of shares of common stock) based on the issuer's achievement of a certain performance milestone with the remaining vesting on the second anniversary of the date of grant as long as the reporting person continues to be employed by the issuer on the vesting dates.
F5 Transaction represents shares of common stock withheld solely for the payment of withholding tax liability associated with the vesting of awards of restricted stock units in accordance with the time periods set forth in such awards.